CLOV vs XYL · rev $1.37B vs P/E 27, rev $8.56B
Clover Health Investments Corp (CLOV) versus Xylem Inc (XYL) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Xylem Inc (XYL) is a specialty industrial machinery company listed on NYSE.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported XYL revenue for 2024-12-31 was $8.56B. Net income was $890.0M. Revenue was up 16.3% from 2023-12-31 to 2024-12-31. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
CLOV currently screens at market cap $1.55B. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
Not investment advice. Open the CLOV and XYL stock pages for the full models.
Not investment advice.